Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check10 days agoChange DetectedThe ClinicalTrials.gov error page footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page previously showing a 403 Forbidden message (and its HTML) was removed, likely restoring normal access to the study details content.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with an access-denied message. This indicates the study details are currently unavailable on the page.SummaryDifference17%

- Check52 days agoChange DetectedAdded a 'Multiple myeloma' topic tag and a MedlinePlus Genetics related topics reference; the site revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check59 days agoChange DetectedRemoved the related topics entries for 'Multiple Myeloma' and the 'MedlinePlus Genetics' link from the study's related topics section.SummaryDifference0.2%

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.